Concepedia

Li-Hong Xia

LX

Statistics

Publications

4

Citations

96

H-Index

4

Active since

2013

Affiliations

First Affiliated Hospital Zhejiang University(Current)

Zhejiang University

Li-Hong Xia is an author at First Affiliated Hospital Zhejiang University specializing in molecular oncology, medicine, and oncology.

Publications per year

2013–2015

4

Publications

4

FBW7 Upregulation Enhances Cisplatin Cytotoxicity in Non-small Cell Lung Cancer Cells

Haogang Yu, Wei Wei, Li-Hong Xia et al. · Asian Pacific Journal of Cancer Prevention · 2013 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

<scp>N</scp>1‐guanyl‐1,7‐diaminoheptane sensitizes bladder cancer cells to doxorubicin by preventing epithelial–mesenchymal transition through inhibition of eukaryotic translation initiation factor 5<scp>A</scp>2 activation

Jin‐Song Yang, Haogang Yu, Mo Shen et al. · Cancer Science · 2013 · 31 citations · Full text

Medicine, Oncology, Pharmacology +15

The decreased expression of miR-625 predicts poor prognosis of esophageal squamous cell carcinoma.

Chuan Li, Dacheng Li, Shusheng Che et al. · PubMed · 2015 · 16 citations

Medicine, Cancer Biology, Oncology +17

Livin and caspase-3 expression are negatively correlated in cervical squamous cell cancer.

Ming Xu, Li-Hong Xia, Ling-Yao Fan et al. · PubMed · 2013 · 13 citations

Medicine, Oncology, Pathology +17

1–4 of 4